Open AccessThe role of angiogenesis inhibitors in the treatment of elderly patients with advanced non-small-cell lung cancer: A meta-analysis of eleven randomized controlled trials
Author(s) -
Rong-Hua Tian,
Xia Wu,
Xia Liu,
Jin-Wang Yang,
Hua-Liang Ji,
Yongjin Yan
Publication year - 2016
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.151950
Subject(s) - medicine , hazard ratio , oncology , lung cancer , meta analysis , randomized controlled trial , subgroup analysis , clinical trial , publication bias , confidence interval , progression free survival , overall survival
Data on the role of angiogenesis inhibitors (AIs) in the treatment of elderly patients with advanced non-small-cell lung cancer (NSCLC) remains limited. We aimed to assess the overall efficacy of AIs-containing regimens in the treatment of advanced NSCLC in this setting.